Multiple Sclerosis
Autologous stem cell transplantation can be beneficial
Published in Blood Weekly, April 3rd, 2003
Enric Carreras and colleagues at the University of Barcelona Hospital Clinic conducted a "phase II trial to evaluate the feasibility and toxicity of CD34+ selected" autologous stem cell transplantation (CD34+/ASCT).
Treatment with CD34+/ASCT slowed or reversed MS progression with limited toxicity, Carreras and coauthors found.
The researchers performed CD34+/ASCT on 15 patients with advanced secondary progressive (SP) or relapsing-remitting (RR) MS. All of the transplanted...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2003-04-03)
More Articles from Blood Weekly
- Stem Cell Transplantation
Donor pretreatment with IL-18 prevents acute GVHD - Epidemiology
Drug use and blood products transmit hepatitis C virus infections in Uzbekistan - HIV/AIDS Therapy
Different blood cell types have varying drug resistance rates - Orthopedics
Extended thromboprophylaxis recommended after hip or knee replacement - Stem Cell Research
Transplanted bone marrow generates new neurons in human brains - Acute Lymphoblastic Leukemia
Bone marrow grafts may be best option with matched unrelated donors - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
